113 related articles for article (PubMed ID: 7696156)
21. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
22. Prognostic markers in node-negative breast cancer: a prospective study.
Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
[TBL] [Abstract][Full Text] [Related]
23. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
24. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
25. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
26. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A
Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of flow cytometric DNA analysis in patients with rectal cancer].
Yamasaki S; Kumashiro R; Yoshitake H; Sano C; Maekawa T; Kido K; Tanaka K; Inutsuka S
Gan To Kagaku Ryoho; 1993 Apr; 20(6):775-9. PubMed ID: 8489285
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of cellular proliferative activity and DNA ploidy as a prognostic factor in breast cancer].
Pisani T; De Iorio P; Cenci M; Midulla C; Valli C; Vecchione A
Minerva Ginecol; 1999; 51(1-2):1-5. PubMed ID: 10230237
[TBL] [Abstract][Full Text] [Related]
31. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
[TBL] [Abstract][Full Text] [Related]
32. Ductal breast carcinomas with whole chromosome gains as a particular subset of near-diploid tumors with different metastasis free survival.
Elie C; Molist R; Asselain B; Dutrillaux B; Muleris M
Breast Cancer Res Treat; 2005 Aug; 92(3):279-85. PubMed ID: 16155799
[TBL] [Abstract][Full Text] [Related]
33. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
34. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
[TBL] [Abstract][Full Text] [Related]
35. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
36. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast.
Romero L; Klein L; Ye W; Holmes D; Soni R; Silberman H; Lagios MD; Silverstein MJ
Am J Surg; 2004 Oct; 188(4):371-6. PubMed ID: 15474428
[TBL] [Abstract][Full Text] [Related]
37. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
38. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
[TBL] [Abstract][Full Text] [Related]
40. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma.
Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B
Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
